CCND1 and neoplasm: Now, in addition to our previously reported MOA of OTI-611 [3,5,6,7], we have uncovered OTI-611’s effects on Cyclin D1 and Ki-67 expression, its induction of G1 cell cycle arrest, and its ability to reduce tumor cell proliferation.